Superworth

AbbVie market cap ABBV

Share price times shares outstanding: what the whole company sells for, since 2013.

Today, Nov 3, 2026
$511.6B
Highest close in our data
$521.1B
Oct 2026

AbbVie is worth $511.6B at the close on Nov 3, 2026, at $289.50 a share.

That is up 32% over the last year and up 147% over five years.

Its highest close in our data was $521.1B in Oct 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$510.4B$351.4B$521.1B+26%
2025$406.5B$300.9B$417.6B+29%
2024$314.6B$277.3B$359.5B+15%
2023$273.6B$237.7B$294.5B−4%
2022$285.8B$233.3B$309.5B+19%
2021$239.4B$180.9B$239.4B+27%
2020$189.2B$101.8B$189.4B+43%
2019$131.9B$95.3B$134.6B−4%
2018$137.1B$120.5B$196.7B−11%
2017$154.4B$97.5B$156.8B+52%
2016$101.8B$86B$109.4B+5%
2015$96.8B$83.3B$113.6B−9%
2014$106.7B$73.8B$111.1B+28%
2013$83.6B$65.5B$83.7Bn/a

Against its peers

Companies in Drug Manufacturers - General nearest AbbVie's size, closest first, today.

CompanyMarket cap
ABBVAbbVie$511.6B
JNJJohnson & Johnson$650.2B
MRKMerck$359.5B
AMGNAmgen$252.3B
GILDGilead Sciences$212.5B
LLYEli Lilly and$1.3T
PFEPfizer$176B
BMYBristol-Myers Squibb$128.7B
Peer median$252.3B

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on AbbVie

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.